提高多发性硬化症临床试验的效率
Ruth Ann Marrie1, Maria Pia Sormani2, Sean Apap Mangion3
1Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Multiple sclerosis (Houndmills, Basingstoke, England)
|August 9, 2023
概括
创新的临床试验设计和中间结果可以提高多发性硬化症 (MS) 研究的效率,尤其是渐进性MS. 这些方法旨在解决更广泛的问题,加快治疗发展.
科学领域:
- 临床试验方法论 临床试验方法论
- 神经免疫学 神经免疫学
- 药物开发 药物开发
背景情况:
- 对于复发性复发性多发性硬化症 (RRMS) 的传统的第三期试验设计是成功的,但在范围,时间和成本上是有限的.
- 在历史上,治疗渐进性多发性硬化症 (MS) 的试验面临着更大的挑战和更低的成功率.
- 现有的设计限制了可以有效调查的研究问题类型.
研究的目的:
- 探索复杂的创新试验设计和中间结果,以提高MS的临床试验效率.
- 扩大临床试验可以解决的问题范围,特别关注渐进性MS.
- 促进对各种形式的多发性硬化症有效治疗方法的开发.
主要方法:
- 一个国际研讨会召集了临床试验设计专家.
- 讨论的重点是与MS研究相关的创新方法和结果措施.
- 专家们就未来试验开发的建议寻求了专家共识.
主要成果:
- 建议包括采用复杂的创新设计和利用生物标志物来丰富渐进性MS试验种群.
- 建议优先考虑针对非炎症机制的中间结果,并评估数据链接的可接受性.
- 建议对儿科试验采用贝叶斯式设计,并为平台试验和注册表提供持续的资金.
结论:
- 新的试验设计和先进的中间结果有可能显著提高MS临床试验的效率.
- 这些进展可以使研究新的治疗问题成为可能,特别是在渐进性多发性硬化症中.
- 这些发现为在多发性硬化症中进行更有效和更全面的临床研究提供了路线图.
相关概念视频
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K